Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Seth Bechis

    TitleAssociate Physician
    SchoolUniversity of California, San Diego
    Address9300 Campus Point Drive #7897
    CA La Jolla 92037
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      Massachusetts General Hospital, Boston, MAResidencyUrology Residency
      UC San Diego, San Diego, CAFellowshipFellowship in Endourology and Robotic Surgery
      University of California, San Francisco, San Francisco, CAM.S.Biomedical Sciences
      University of California, San Francisco, San Francisco, CAM.D.Medicine
      Harvard University, Cambridge, MAA.B.Chemistry

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Wang Z, Hu L, Salari K, Bechis S, Ge R, Wu S, Rassoulian C, Pham J, Wu CL, Tabatabaei S, Douglas SW, Olumi AF. Androgenic to estrogenic switch in human adult prostate gland is regulated by epigenetic silencing of steroid 5a-reductase 2. J Pathol. 2017 Sep 20. PMID: 28940538.
        View in: PubMed
      2. Wintner A, Kim MM, Bechis S, Kreydin EI. Voiding Dysfunction in Multiple Sclerosis. Semin Neurol. 2016 Apr; 36(2):219-20. PMID: 27116728.
        View in: PubMed
      3. Wintner A, Kim MM, Bechis S, Kreydin EI. Voiding Dysfunction in Multiple Sclerosis. Semin Neurol. 2016 Feb; 36(1):34-40. PMID: 26866494.
        View in: PubMed
      4. Sanchez A, Rodríguez D, Allard CB, Bechis S, Sullivan RJ, Boeke CE, Kuppermann D, Cheng JS, Barrisford GW, Preston MA, Feldman AS. Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort. Urol Oncol. 2016 Apr; 34(4):166.e7-14. PMID: 26739672.
        View in: PubMed
      5. Bechis S, Otsetov AG, Ge R, Wang Z, Vangel MG, Wu CL, Tabatabaei S, Olumi AF. Age and Obesity Promote Methylation and Suppression of 5a-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia. J Urol. 2015 Oct; 194(4):1031-7. PMID: 25916673; PMCID: PMC4761873.
      6. Ge R, Wang Z, Bechis S, Otsetov AG, Hua S, Wu S, Wu CL, Tabatabaei S, Olumi AF. DNA methyl transferase 1 reduces expression of SRD5A2 in the aging adult prostate. Am J Pathol. 2015 Mar; 185(3):870-82. PMID: 25700986; PMCID: PMC4348471.
      7. Bechis S, Eisner BH. Editorial comment. Urology. 2014 Sep; 84(3):542-3. PMID: 25168530.
        View in: PubMed
      8. Bechis S, Eisner BH. The STONE score can help diagnose urolithiasis and decrease the use of CT scans. Evid Based Med. 2014 Dec; 19(6):234. PMID: 25053641.
        View in: PubMed
      9. Bechis S, Otsetov AG, Ge R, Olumi AF. Personalized medicine for the management of benign prostatic hyperplasia. J Urol. 2014 Jul; 192(1):16-23. PMID: 24582540; PMCID: PMC4143483.
      10. Costa MJ, Wu X, Cuervo H, Srinivasan R, Bechis S, Cheang E, Marjanovic O, Gridley T, Cvetic CA, Wang RA. Notch4 is required for tumor onset and perfusion. Vasc Cell. 2013; 5(1):7. PMID: 23601498; PMCID: PMC3644271.
      11. Bechis S, Carroll PR, Cooperberg MR. Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol. 2011 Jan 10; 29(2):235-41. PMID: 21135285; PMCID: PMC3058279.
      12. Eisner BH, Porten SP, Bechis S, Stoller ML. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol. 2010 Jun; 183(6):2244-8. PMID: 20400141.
        View in: PubMed
      13. Eisner BH, Porten SP, Bechis S, Stoller ML. The role of race in determining 24-hour urine composition in white and Asian/Pacific Islander stone formers. J Urol. 2010 Apr; 183(4):1407-11. PMID: 20171692.
        View in: PubMed
      14. Eisner BH, Porten SP, Bechis S, Stoller ML. Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. J Urol. 2010 Feb; 183(2):576-9. PMID: 20018328.
        View in: PubMed
      15. Kouros-Mehr H, Kim JW, Bechis S, Werb Z. GATA-3 and the regulation of the mammary luminal cell fate. Curr Opin Cell Biol. 2008 Apr; 20(2):164-70. PMID: 18358709; PMCID: PMC2397451.
      16. Kouros-Mehr H, Bechis S, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell. 2008 Feb; 13(2):141-52. PMID: 18242514; PMCID: PMC2262951.
      17. Wei H, Ruthenburg AJ, Bechis S, Verdine GL. Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase. J Biol Chem. 2005 Nov 04; 280(44):37041-7. PMID: 16100112.
        View in: PubMed